David D. Roberts - Bethesda MD Henry C. Krutzsch - Bethesda MD John M. Sipes - Cabin John MD Eric Negre - Bethesda MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 3800 C07K 700 C07K 706 C07K 708
US Classification:
514 13
Abstract:
Peptides derived from the second type 1 repeat of human endothelial cell thrombospondin which bind to the gelatin-binding domain of fibronectin have been isolated and synthetically produced. The peptides can be used to bind to fibronectin or other related collagen-binding proteins to inhibit fibronectin-dependent cell adhesion to collagen matrices and to inhibit interactions with collagen of other proteins that share homologies with the gelatin-binding domain of fibronectin.
Peptide Inhibitors Of Fibronectin And Related Collagen-Binding Proteins
David D. Roberts - Bethesda MD Henry C. Krutzsch - Bethesda MD John M. Sipes - Cabin John MD Eric Negre - Bethesda MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A61K 3800 C07K 706 C07K 708 C07K 700
US Classification:
514 12
Abstract:
Peptides derived from the second type 1 repeat of human endothelial cell thrombospondin which bind to the gelatin-binding domain of fibronectin have been isolated and synthetically produced. The peptides can be used to bind to fibronectin or other related collagen-binding proteins to inhibit fibronectin-dependent cell adhesion to collagen matrices and to inhibit interactions with collagen of other proteins that share homologies with the gelatin-binding domain of fibronectin.